Free Trial

4basebio (4BB) Insider Trading & Ownership

GBX 1,325 0.00 (0.00%)
(As of 11/15/2024 ET)

4basebio (LON:4BB) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
68.44%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
£73,910.00
Number Of
Insiders Selling
(Last 3 Years)
0
Get 4BB Insider Trade Alerts

Want to know when executives and insiders are buying or selling 4basebio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

4BB Insider Buying and Selling by Quarter

4basebio Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/16/2022David John RothInsiderBuy5,000GBX 430£21,500
5/12/2022Heikki LanckrietInsiderBuy3,000GBX 470£14,100
5/9/2022Heikki LanckrietInsiderBuy500GBX 500£2,500
12/20/2021Heikki LanckrietInsiderBuy1,000GBX 650£6,500
12/17/2021Heikki LanckrietInsiderBuy1,500GBX 650£9,750
12/13/2021Heikki LanckrietInsiderBuy3,000GBX 652£19,560
(Data available from 1/1/2013 forward)

4BB Insider Trading Activity - Frequently Asked Questions

The list of insiders at 4basebio includes David John Roth, and Heikki Lanckriet. Learn more on insiders at 4BB.

68.44% of 4basebio stock is owned by insiders. Learn more on 4BB's insider holdings.

4basebio Key Executives

  • Dr. Heikki Lanckriet Ph.D. (Age 47)
    CEO, Chief Scientific Officer & Executive Director
    Compensation: $441.2k
  • Mr. David Roth (Age 57)
    CFO, Company Secretary & Executive Director
    Compensation: $317.9k


This page (LON:4BB) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners